HALO Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: HALO Shares Outstanding History and HALO YTD Return |
HALO Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: HALO Shares Outstanding History and HALO YTD Return |
HALO Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+15.46% CAGR Mouse over chart for data details
|
HALO Stock Price Chart |
About Halozyme Therapeutics Inc |
Halozyme Therapeutics is a biopharma technology platform company that provides solutions to improve patient experience and outcomes. Co.'s approved product and its collaborators' approved products and product candidates are based on rHuPH20, its patented recombinant human hyaluronidase enzyme. Co. refers to the application of rHuPH20 to facilitate the delivery of other drugs or fluids as its ENHANZE® drug delivery technology (ENHANZE). Co. licenses the ENHANZE technology to form collaborations with biopharmaceutical companies that develop or market drugs requiring or benefiting from injection via the subcutaneous route of administration. We show 57 historical shares outstanding datapoints in our HALO shares outstanding history coverage, used to compute HALO market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing HALO market cap history over the course of time is important for investors interested in comparing HALO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of HALO versus a peer is one thing; comparing HALO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like HALO can fluctuate over the course of history. With this page we aim to empower investors researching HALO by allowing them to research the HALO market cap history. |
HALO Current Stock Quote |
Free HALO Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
HALO Share Performance |
Market Cap Peers |
Halozyme Therapeutics (HALO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
HARP Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.